OrganiGram Holdings Financial Statements (OGI) |
||||||||||
OrganiGram Holdingssmart-lab.ru | % | 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | |||
---|---|---|---|---|---|---|---|---|---|---|
Report date | 23.11.2021 | 31.08.2022 | 29.11.2022 | 30.09.2023 | 19.12.2023 | 13.08.2024 | ||||
Currency | CAD | CAD | CAD | CAD | CAD | CAD | ||||
Financial report URL | ||||||||||
Revenue, C$ | ? | 79 163 000 | 145 809 000 | 145 809 000 | 149 205 728 | 149 205 243 | 152 771 000 | |||
Operating Income, C$ | -91 820 000 | -38 752 000 | -38 752 000 | -112 404 370 | -48 790 158 | -69 731 000 | ||||
EBITDA, C$ | ? | -42 924 000 | -15 209 000 | -15 209 000 | -88 230 750 | -25 365 233 | -74 044 000 | |||
Net profit, C$ | ? | -132 546 000 | -14 283 000 | -14 283 000 | -229 478 611 | -229 477 865 | -67 082 000 | |||
OCF, C$ | ? | -28 589 000 | -36 211 000 | -36 211 000 | -35 189 000 | -35 795 080 | -11 349 000 | |||
CAPEX, C$ | ? | 12 329 000 | 48 778 000 | 48 778 000 | 30 428 000 | 26 900 310 | 3 480 000 | |||
FCF, C$ | ? | -40 918 000 | -84 989 000 | -84 989 000 | -65 617 000 | -62 695 390 | -14 829 000 | |||
Dividend payout, C$ | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
OPEX, C$ | 44 440 000 | 70 321 000 | 70 321 000 | 78 597 492 | 271 477 869 | 88 623 000 | ||||
Cost of production, C$ | 107 562 000 | 114 240 000 | 114 240 000 | 183 012 610 | 114 132 010 | 133 879 000 | ||||
R&D, C$ | 3 450 000 | 5 962 000 | 5 962 000 | 12 185 579 | 12 185 539 | 12 139 000 | ||||
Interest expenses, C$ | 2 960 000 | 429 000 | 429 000 | 277 847 | 277 847 | 230 000 | ||||
Assets, C$ | 554 017 000 | 577 107 000 | 577 107 000 | 298 455 000 | 298 455 000 | 354 748 000 | ||||
Net Assets, C$ | ? | 479 805 000 | 508 058 000 | 508 058 000 | 271 623 000 | 271 623 000 | 295 856 000 | |||
Debt, C$ | 4 961 000 | 3 357 000 | 3 357 000 | 4 719 000 | 3 706 000 | 100 000 | ||||
Cash, C$ | 183 843 000 | 98 911 000 | 98 911 000 | 33 864 000 | 33 864 000 | 80 067 000 | ||||
Net debt, C$ | -178 882 000 | -95 554 000 | -95 554 000 | -29 145 000 | -30 158 000 | -79 967 000 | ||||
Ordinary share price, rub | 10.7 | 4.28 | 4.28 | 1.32 | 1.32 | 1.10 | ||||
Number of ordinary shares, mln | 64 029 982 | 77 228 917 | 77 228 917 | 81 292 869 | 81 292 885 | 103 801 351 | ||||
Market cap, C$ | 683 840 208 | 330 539 765 | 330 539 765 | 107 306 587 | 107 306 608 | 114 181 486 | ||||
EV, C$ | ? | 504 958 208 | 234 985 765 | 234 985 765 | 78 161 587 | 77 148 608 | 34 214 486 | |||
Book value, C$ | 462 759 000 | 451 819 000 | 451 819 000 | 260 999 000 | 260 999 000 | 295 856 000 | ||||
EPS, rub | ? | -2.07 | -0.18 | -0.18 | -2.82 | -2.82 | -0.65 | |||
FCF/share, rub | -0.64 | -1.10 | -1.10 | -0.81 | -0.77 | -0.14 | ||||
BV/share, rub | 7.23 | 5.85 | 5.85 | 3.21 | 3.21 | 2.85 | ||||
EBITDA margin, % | ? | -54.2% | -10.4% | -10.4% | -59.1% | -17.0% | -48.5% | |||
Net margin, % | ? | -167.4% | -9.80% | -9.80% | -153.8% | -153.8% | -43.9% | |||
FCF yield, % | ? | -5.98% | -25.7% | -25.7% | -61.1% | -58.4% | -13.0% | |||
ROE, % | ? | -27.6% | -2.81% | -2.81% | -84.5% | -84.5% | -22.7% | |||
ROA, % | ? | -23.9% | -2.47% | -2.47% | -76.9% | -76.9% | -18.9% | |||
P/E | ? | -5.16 | -23.1 | -23.1 | -0.47 | -0.47 | -1.70 | |||
P/FCF | -16.7 | -3.89 | -3.89 | -1.64 | -1.71 | -7.70 | ||||
P/S | ? | 8.64 | 2.27 | 2.27 | 0.72 | 0.72 | 0.75 | |||
P/BV | ? | 1.48 | 0.73 | 0.73 | 0.41 | 0.41 | 0.39 | |||
EV/EBITDA | ? | -11.8 | -15.5 | -15.5 | -0.89 | -3.04 | -0.46 | |||
Debt/EBITDA | 4.17 | 6.28 | 6.28 | 0.33 | 1.19 | 1.08 | ||||
R&D/CAPEX, % | 28.0% | 12.2% | 12.2% | 40.0% | 45.3% | 348.8% | ||||
CAPEX/Revenue, % | 15.6% | 33.5% | 33.5% | 20.4% | 18.0% | 2.28% | ||||
OrganiGram Holdings shareholders |